[
    [
        {
            "time": "2021-07-15",
            "original_text": "上海医药术后镇痛药注射用帕瑞昔布钠获批 竞争对手达25家",
            "features": {
                "keywords": [
                    "上海医药",
                    "术后镇痛药",
                    "注射用帕瑞昔布钠",
                    "获批",
                    "竞争对手",
                    "25家"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "上海医药术后镇痛药注射用帕瑞昔布钠获批 竞争对手达25家",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]